MONECO Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

MONECO Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,931	Closed	-$219K	–	250
2021 Q3	$219K	Buy	2,931 +3	+0.1%	+$252	0.09%	230
2021 Q2	$271K	Buy	2,928 +455	+18%	+$38.7K	0.12%	168
2021 Q1	$219K	Buy	+2,473	New	+$245K	0.11%	198

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MONECO Advisors's ARKG Position: Q4 2021 in Review

MONECO Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 2,931 shares — an estimated $219K sold.

MONECO Advisors first reported a position in ARKG in Q1 2021 and held it in 3 quarters. The position peaked at $271K in Q2 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

MONECO Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
MONECO Advisors sold 2,931 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $219K.
MONECO Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 3 quarters.
MONECO Advisors's ARK Genomic Revolution ETF position peaked at $271K in Q2 2021.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on MONECO Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.